These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16029155)

  • 1. Thrombin inhibition by the highly selective 'reversible suicide substrate' N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester.
    Ascenzi P; Gallina C; Bolognesi M
    Protein Pept Lett; 2005 Jul; 12(5):433-8. PubMed ID: 16029155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
    De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
    J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin.
    Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine proteinase inhibition by the active site titrant N alpha-(N, N-dimethylcarbamoyl)-alpha-azaornithine p-nitrophenyl ester. A comparative study.
    Ascenzi P; Balliano G; Gallina C; Polticelli F; Bolognesi M
    Eur J Biochem; 2000 Feb; 267(4):1239-46. PubMed ID: 10672036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
    Gorman JJ
    Biochim Biophys Acta; 1975 Dec; 412(2):273-82. PubMed ID: 1191680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B; Richter M; Hauptmann J; Markwardt F
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals, new orally active stable analogues of D-Phe-Pro-Arg-H.
    Bajusz S; Barabas E; Fauszt I; Feher A; Horvath G; Juhasz A; Szabo GA; Szell E
    Semin Thromb Hemost; 1996; 22(3):243-6. PubMed ID: 8836008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anophelin: kinetics and mechanism of thrombin inhibition.
    Francischetti IM; Valenzuela JG; Ribeiro JM
    Biochemistry; 1999 Dec; 38(50):16678-85. PubMed ID: 10600131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based understanding of ligand affinity using human thrombin as a model system.
    Nienaber VL; Mersinger LJ; Kettner CA
    Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogen-substrate assay--as a tool for monitoring a new thrombin inhibitor.
    Rásky K; Pátfalusi M; Vereczkey L
    Acta Pharm Hung; 1993 Jan; 63(1):3-12. PubMed ID: 8452033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution conformation of (D)Phe-Pro-containing peptides: implications on the activity of Ac-(D)Phe-Pro-boroArg-OH, a potent thrombin inhibitor.
    Lim MS; Johnston ER; Kettner CA
    J Med Chem; 1993 Jun; 36(13):1831-8. PubMed ID: 8515421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protons on the thrombin-fibrinogen interaction.
    Picozzi M; Landolfi R; De Cristofaro R
    Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of substrates and reversible inhibitors binding to the active site cleft of human alpha-thrombin.
    De Cristofaro R; Landolfi R
    J Mol Biol; 1994 Jun; 239(4):569-77. PubMed ID: 8006969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of alpha-N-(p-toluenesulphonyl)-p-guanidino-L-phenylalanine methyl ester with thrombin and trypsin.
    Klausner YS; Rigbi M; Ticho T; De Jong PJ; Neginsky EJ; Rinott Y
    Biochem J; 1978 Jan; 169(1):157-67. PubMed ID: 629742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.
    Brezniak DV; Brower MS; Witting JI; Walz DA; Fenton JW
    Biochemistry; 1990 Apr; 29(14):3536-42. PubMed ID: 2354150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
    Bock PE
    Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.